Board of Directors

Mr. Göran Pettersson
Mr. Göran Pettersson
Board Member and Chairman since 2015.

Born: 1945.

Göran has served as Chairman of Axelar AB until June 2014, Medivir AB (publ) until May 2014, and OxyPharma AB until May 2012. He was Board Member of Recipharm AB (publ) until May 2016. He has served as Board Member and Chief Executive Officer of Meda Sverige AB, which ceased to exist following a merger in July 2014. Göran held leading positions in Astrazeneca, KabiVitrum, and Pharmacia. He holds an M.Pharm Sc. from Uppsala University and an MBA from IHM Business School in Stockholm.

Other Assignments: Göran serves as Chairman of the Board of Mobidiag Sverige AB; Board Member of G. Pettersson & Partners AB, Pfizer Pensionsstiftelse I, Mobidiag OY, Bioretec OY and Bostadsrättsföreningen Trumslagaren 3; and Deputy Board Member of Karl Jungstedt AB.
Independent in relation to Promore Pharma and its senior executives: Yes.
Independent in relation to major shareholders (per today): Yes.
Share Holding in Promore Pharma: No current holding.

Mrs. Marianne Dicander Alexandersson
Mrs. Marianne Dicander Alexandersson
Board Member since 2017

Born: 1959.

Marianne has served as Chief Executive Officer of the Sixth AP Fund, Deputy Chief Executive Officer of Apoteket AB, Chief Executive Officer of Kronans Droghandel. She has experience in quality and market from various industries such as car, plastics, chemical industry, pharmaceutical and healthcare logistics. Marianne has served as Board member of West Atlantic AB (publ) until March 2016, Mölnlycke Holding AB, Mölnlycke AB, Castellum AB and MHC Sweden AB until March 2015, Easy Lighting Scandinavia AB until January 2015, Bariatric and Diabetes Center Ajman AB until November 2013, and Chalmers University of Technology AB until August 2013. She was Chairman and Chief Executive Officer of Global Health Partner Swe AB and Chief Executive Officer of Global Health Partner AB until November 2013. She holds an M.Sc. in Chemical Engineering from Chalmers Technical College in Gothenburg.

Other Assignments: Marianne serves as Chairman of Sahlgrenska Science Park AB; Board Member and Chief Executive Officer of MDA Management AB; Board member of Recipharm AB (publ), Enzymatica AB (publ), Praktikertjänst Aktiebolag, Camurus AB, AdderaCare AB and Xperentia AB.
Independent in relation to Promore Pharma and its senior executives: Yes.
Independent in relation to major shareholders (per today): Yes.
Share Holding in Promore Pharma: No current holding.

Dr. Torsten Goesch
Dr. Torsten Goesch
Board Member since 2015

Born: 1959.

Torsten serves as Senior Executive in Rosetta, where he is responsible for investments. He has served as Board Member of several biotechnology companies and he is a founder of a consulting company in the biotechnology industry. Torsten has served as Board Member of STI Ltd until 2014 and Cytochroma Ltd until 2013. He holds an M.D. and a Ph.D. from Heinrich Heine University Düsseldorf, Germany and an MBA from the Kellogg School of Management in Evanston, USA.

Other Assignments: Torsten serves as Chairman of Biosergen AS and Biosergen China JV; Board Member of Rosetta, Forward Pharma, Vistagen Pte Ltd, Dilafor AB, Dilaforette AB, Karolinska Development Invest AB, Eyesense GmbH and Dr. Goesch Pharma Pte Ltd.
Independent in relation to Promore Pharma and its senior executives: Yes.
Independent in relation to major shareholders (per today): No.
Share Holding in Promore Pharma: No current holding.

Dr. Satyendra Kumar
Dr. Satyendra Kumar
Board Member since 2016

Born: 1954

Satyendra serves as Vice President Research and Development for PharmaResearch Products Ltd. He has previously worked with licensing, alliances and business development for Daewoong Pharmaceutical Company Ltd and with establishment of international distribution for Samyang’s medical technology and pharmaceutical business. Satyendra holds an M.D. from the Birla Institute of Technology and Science in Pilani, India and a Ph.D. from Seoul National University in Seoul, Korea.

Independent in relation to Promore Pharma and its senior executives: Yes.
Independent in relation to major shareholders (per today): No.
Share Holding in Promore Pharma: No current holding.

Mr. Göran Linder
Mr. Göran Linder
Board Member since 2015

Born: 1962.

Göran serves as Senior Executive in several investment companies. He has more than 25 years of experience in sales, business development and management with extensive knowledge in technology-related areas. He has served as Board Member of Midroc Finans AB until February 2017, Crossborder Technologies AB until September 2016, Lamera AB until August 2015, and HCCI Technology AB until November 2012. He has served as Executive Vice President of Midroc New Technology AB until January 2017. He was Deputy Director of Reosense AB and Microfluid AB until April 2014.

Göran holds an M.Sc. from the KTH Royal Institute of Technology in Stockholm.

Other Assignments: Göran is a member of the Board of Directors and Chief Executive Officer of Midroc New Technology AB and Midroc Invest AB. He serves as Board Member of Airgrinder AB, Jensen Devices AB, Nilsson Special Vehicles Ltd, Minesto AB, Powercell Sweden AB (publ), Crunchfish AB, M&J by Malin & Johanna AB and Minesto Warrants One AB; Executive Vice President of Midroc Finans AB; Deputy Board Member of Lamera AB, Heliospectra AB (publ), Air to Air Sweden AB, Crossborder Technologies AB, SolarWave AB and Heliospectra Personal AB.
Independent in relation to Promore Pharma and its senior executives: Yes.
Independent in relation to major shareholders (per today): No.
Share Holding in Promore Pharma: No current holding.